Pneumocystosis

Smith, James W.; Bartlett, Marilyn S.

doi:10.1007/978-1-4612-3898-0_100

Search citation statements

Order By: Relevance

Paper Sections

Select...

Dna Amplification By Pcr On the Diagnosis Of Pneum Ocystis C1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1993

1995

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…BOT staining was performed following standard proce dures [8]; indirect IF was performed using monoclonal antibodies specific for antigens of the cyst wall according to the manufacturer's instructions (Monofluokit P. cari nii, Diagnostics Pasteur, Paris, France).…”

Section: Dna Amplification By Pcr On the Diagnosis Of Pneum Ocystis Cmentioning

confidence: 99%

Role of Pneumocystiscarinii DNA Amplification by PCR on the Diagnosis of PneumocystiscariniiPneumonia in Patients with Haematologic Malignant Diseases: Report of Four Cases

et al. 1995

View full text Add to dashboard Cite

Section: Dna Amplification By Pcr On the Diagnosis Of Pneum Ocystis Cmentioning

confidence: 99%

Role of Pneumocystiscarinii DNA Amplification by PCR on the Diagnosis of PneumocystiscariniiPneumonia in Patients with Haematologic Malignant Diseases: Report of Four Cases

et al. 1995

View full text Add to dashboard Cite

Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence

Varthalitis

Aoun

Daneau

et al. 1993

Cancer

View full text Add to dashboard Cite

Background. The incidence of Pneumocystis carinii pneumonia (PCP) is increasing in patients with cancer. Possible nosocomial transmission from patients with acquired immune deficiency syndrome to those with cancer has been advocated. Methods. Retrospectively, 17 patients with cancer were reviewed who had 20 PCP episodes that occurred during a 3‐year period (1988–1990). Results. Twelve patients had a hematologic malignant lesion, and five had a solid tumor as their underlying disease. Cytotoxic and/or immunosuppressive drugs were used in 16 patients (94%). The clinical presentation varied from fulminant to inapparent pneumonia. Clinical improvement and survival after appropriate therapy occurred in 12 patients (70%), whereas the remaining 5 patients died within 4 weeks of trimethoprim‐sulfamethoxazole treatment initiation. In two patients, pentamidine was substituted. Complications of treatment occurred in six patients (35%). When survivors were compared with nonsurvivors, there was no difference in mean age, leukocyte counts, arterial oxygen tension, or duration of symptoms before treatment. Conclusions. In this series, nosocomial transmission of PCP was unlikely. Prophylaxis after a first episode of PCP should be considered in patients who will remain immunosuppressed.

show abstract

Pneumocystosis

Cited by 2 publications

References 39 publications

Role of <i>Pneumocysti</i><i>s</i><i>carinii</i> DNA Amplification by PCR on the Diagnosis of <i>Pneumocystis</i><i>carinii</i><i>Pneumonia</i> in Patients with Haematologic Malignant Diseases: Report of Four Cases

Role of <i>Pneumocysti</i><i>s</i><i>carinii</i> DNA Amplification by PCR on the Diagnosis of <i>Pneumocystis</i><i>carinii</i><i>Pneumonia</i> in Patients with Haematologic Malignant Diseases: Report of Four Cases

Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence

Contact Info

Product

Resources

About